Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/13/1996 | CA2206127A1 Method of detection of nucleic acids with a specific sequence composition |
06/13/1996 | CA2205561A1 Enhanced biotin biosynthesis in plant tissue |
06/12/1996 | EP0716148A2 Recombinant alphavirus vectors |
06/12/1996 | EP0716147A2 Methods for producing transgenic plants |
06/12/1996 | EP0716146A2 A novel stem cell marker protein, antibodies thereto, compositions thereof and nucleotide sequences encoding said protein |
06/12/1996 | EP0716145A1 Improved steroid hormone superfamily receptors, and their use in screening and identifying potential antagonists |
06/12/1996 | EP0716095A1 Method for quantitative determination of fas antigen |
06/12/1996 | EP0716094A1 Process for purifying hepatitis B viral surface antigen comprising preS2 peptide |
06/12/1996 | EP0715719A1 Assay device with captured particle reagent |
06/12/1996 | EP0715656A1 Transcription factor-dna binding assay |
06/12/1996 | EP0715654A1 Mycoplasma expression system |
06/12/1996 | EP0715653A1 Humanised antibodies |
06/12/1996 | EP0715633A1 Haemopoietic growth factor antagonists |
06/12/1996 | EP0715632A1 Anti-sense oligonucleotides for aromatase inhibition |
06/12/1996 | EP0715523A1 Purine nucleoside phosphorylase gene therapy for human malignancy |
06/12/1996 | EP0690732A4 Gas driven gene delivery instrument |
06/12/1996 | EP0570496A4 Polymorphic dna markers in bovidae |
06/12/1996 | EP0538353B1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
06/12/1996 | EP0498843B1 Oligonucleotide analogs with novel linkages |
06/12/1996 | EP0463151B1 Generation of xenogeneic antibodies |
06/12/1996 | EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity |
06/12/1996 | EP0414915B1 New superoxide dismutase |
06/12/1996 | EP0373192B1 Diagnostic genes for toxoplasmosis |
06/12/1996 | EP0293471B1 Primary biliary cirrhosis autoantigen |
06/12/1996 | CN1124502A Mammal cell lines and method of obtaining glycoproteins |
06/12/1996 | CN1124501A Anti-EGFR single-chain Fvs and anti-EGFR antibodies |
06/12/1996 | CN1124460A Gas driven gene delivery instrument |
06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
06/12/1996 | CN1124294A Method for the sensitive detection of nuceic acids |
06/12/1996 | CN1124142A Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
06/12/1996 | CN1032019C Process for recombinant biocides using organisms |
06/11/1996 | US5525717 Support-bound nucletide probe for neisseria gonorrhoeae |
06/11/1996 | US5525716 Polynucleotides for genetic engineering propagation |
06/11/1996 | US5525715 Codes specific polypeptide; useful vaccine to immunize human infected from polio virus |
06/11/1996 | US5525713 DNA encoding polypeptides enabling sorting of proteins to vacuoles in plants |
06/11/1996 | US5525711 Monomers for dna amplification procedures |
06/11/1996 | US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells |
06/11/1996 | US5525513 Isolated mammalian dna sequence which hybridizes to specified primers |
06/11/1996 | US5525510 Injector for accelerating carrier particles, with coatings containing genetic material, in high speed gas stream which separates from particles just before they impact living tissues |
06/11/1996 | US5525508 Purified antigen derived from homogenizing nematodes, extracting and chromatographing on wheat-germ lectin sepharose column |
06/11/1996 | US5525507 Enhancing feel, appearance and/or color of cellulosic fabrics by treating with modified fungal cellulase which comprises at least ten percent endoglucanase and is free of all cellobiohydrolase i |
06/11/1996 | US5525502 DNA encoding chitin deacetylase |
06/11/1996 | US5525497 Pure nucleic acid which codes for a yeast polymerase |
06/11/1996 | US5525496 DNA sequence encoding sterol Δ14 reductase |
06/11/1996 | US5525494 Amplification processes |
06/11/1996 | US5525493 Polymerase chain reaction |
06/11/1996 | US5525491 Serine-rich peptide linkers |
06/11/1996 | US5525490 Yeast cell analysis to screen for molecules that can inhibit protein-protein complexes |
06/11/1996 | US5525489 Antipertussis vaccines |
06/11/1996 | US5525488 Nonchromosomal dna encoding inhibin alpha chain polypeptide having specified sequence |
06/11/1996 | US5525487 DNA encoding I-CAM related protein |
06/11/1996 | US5525486 Genetic engineering |
06/11/1996 | US5525484 Genetically engineered bacteria or yeast cells containing genetic material from recombinant dna which codes for bovine rennin |
06/11/1996 | US5525468 Assay for Ribozyme target site |
06/11/1996 | US5525467 Detection, diagnosis, therapy of alzheimer's disease |
06/11/1996 | US5525463 Method and reagents for detection of mycobacteria using superoxide dismutase gene targeting |
06/11/1996 | US5525337 Detecting tumor cells by removing tissue or fluid sample, reacting with antibody capable of binding to surface antigen, detecting presence of antibody-antigen complex |
06/11/1996 | US5525319 Boron silicates, aluminum silicates, and phosphosilicates for purification of DNA |
06/11/1996 | EP0722489A4 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
06/11/1996 | CA2093428C Methods for treating cotton-containing fabrics with cellulase |
06/11/1996 | CA2078365C Pichia pastoris linear plasmids and dna fragments thereof |
06/11/1996 | CA2071935C Method for evaluating the adequacy of clinical specimens for hybridization assays and kit for performing the evaluation |
06/11/1996 | CA2012838C Dna probe for lactobacillus delbrueckii |
06/11/1996 | CA2012835C Dna probe for lactobacillus helveticus |
06/11/1996 | CA2005950C Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein |
06/11/1996 | CA1338381C Minactivin - (plasminogen activator inhibitor-2) |
06/11/1996 | CA1338380C Shuttle vector |
06/09/1996 | CA2164374A1 Method for quantitative determination of fas antigen |
06/07/1996 | WO1996017869A2 Interleukin-6 (il-6) antagonists |
06/07/1996 | CA2177837A1 Interleukin-6 (il-6) antagonists |
06/07/1996 | CA2141708A1 Nucleotide sequences encoding a novel stem cell marker protein, amino acid sequences of the protein, methods for expressing the protein, a composition of isolated protein, and antibodies specific to the protein |
06/06/1996 | WO1996017086A1 Enzymatic dna molecules |
06/06/1996 | WO1996017084A1 A high-throughput screening assay for inhibitors of nucleic acid polymerases |
06/06/1996 | WO1996017082A2 Compound microsatellite primers for the detection of genetic polymorphisms |
06/06/1996 | WO1996017079A1 Terminal repeat amplification method |
06/06/1996 | WO1996017074A2 Rna polymerase ii peptides and methods of use |
06/06/1996 | WO1996017073A1 Process for producing transformed cell |
06/06/1996 | WO1996017072A2 Recombinant alphavirus vectors |
06/06/1996 | WO1996017071A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
06/06/1996 | WO1996017070A1 Method of preparing a viral vector by homologous intermolecular recombination |
06/06/1996 | WO1996017069A2 Transgenic plants with improved biomass production |
06/06/1996 | WO1996017068A2 Pathogen-resistant plants and method for producing them |
06/06/1996 | WO1996017067A1 Method for secreting thrombopoietin polypeptides |
06/06/1996 | WO1996017066A1 Screening model |
06/06/1996 | WO1996017065A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits |
06/06/1996 | WO1996017064A1 Phenylalanine free proteins |
06/06/1996 | WO1996017063A1 Plasmids suitable for il-2 expression |
06/06/1996 | WO1996017062A1 Low molecular weight thrombopoietin |
06/06/1996 | WO1996017061A1 An sh3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof |
06/06/1996 | WO1996017060A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
06/06/1996 | WO1996017059A2 Receptor for cell-binding domain of thrombospondins |
06/06/1996 | WO1996017058A1 Denatured low-density lipoprotein receptor |
06/06/1996 | WO1996017057A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
06/06/1996 | WO1996017056A1 Hypermutagenesis |
06/06/1996 | WO1996017055A1 Carrier protein driven crystallization of a peptide or polypeptide |
06/06/1996 | WO1996017054A1 Method and compositions for reducing cholesterol absorption |
06/06/1996 | WO1996017053A1 Vectors for tissue-specific replication |
06/06/1996 | WO1996016990A1 Humanized antibodies to cd38 |
06/06/1996 | WO1996016988A1 Reagents and processes for targeting mutant epidermal growth factor receptors |
06/06/1996 | WO1996016979A1 Expressed chemokines, their production and uses |